Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 595 of the 598 references it cites were found in a registry or an index.

Transforming growth factor‐β in stem cells and tissue homeostasis

Open access

Abstract

TGF-β 1-3 are unique multi-functional growth factors that are only expressed in mammals, and mainly secreted and stored as a latent complex in the extracellular matrix (ECM). The biological functions of TGF-β in adults can only be delivered after ligand activation, mostly in response to environmental perturbations. Although involved in multiple biological and pathological processes of the human body, the exact roles of TGF-β in maintaining stem cells and tissue homeostasis have not been well-documented until recent advances, which delineate their functions in a given context. Our recent findings, along with data reported by others, have clearly shown that temporal and spatial activation of TGF-β is involved in the recruitment of stem/progenitor cell participation in tissue regeneration/remodeling process, whereas sustained abnormalities in TGF-β ligand activation, regardless of genetic or environmental origin, will inevitably disrupt the normal physiology and lead to pathobiology of major diseases. Modulation of TGF-β signaling with different approaches has proven effective pre-clinically in the treatment of multiple pathologies such as sclerosis/fibrosis, tumor metastasis, osteoarthritis, and immune disorders. Thus, further elucidation of the mechanisms by which TGF-β is activated in different tissues/organs and how targeted cells respond in a context-dependent way can likely be translated with clinical benefits in the management of a broad range of diseases with the involvement of TGF-β.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41413-017-0005-4

Cites

595 of 595 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 A model of integrin-mediated TGF-β activation during tissue/organ fibrosis. Epithelial cells activate TGF-β by enriching the latent complex through αvβ8-RGD association and recruiting membrane-bound matrix metalloproteinases (e.g., MMP-14) in proximity for further proteolytic cleavage ①. Active TGF-β can act on resident fibroblasts, inducing its trans-differentiation into myofibroblasts, which are the major contributor to excessive ECM (e.g., collagen) deposition and fibrosis. The myofibroblasts can further activate TGF-β in a contractile force-dependent manner through the αvβ6-RGD association ②. The active TGF-β can in turn act on epithelial cells, fibroblasts, and myofibroblasts in a paracrine/autocine manner, and thus form a feed-forward loop for a sustained TGF-β activation and fibrogenesis. Of note, sustained activation of TGF-β can also induce the epithelial–mesenchymal transition (EMT) of epithelial cells with the assistance of integrin α3β1, which forms a complex with TGF-β type I and II receptors (TβRI/II) and E-cadherin, facilitating β-catenin/Smad2 complex formation and nuclear translocation. LAP: latency-associated peptide, LTBP: latent TGF-β binding protein, SLC: small latent complex, LLC: large latent complex.
Fig. 1 A model of integrin-mediated TGF-β activation during tissue/organ fibrosis. Epithelial cells activate TGF-β by enriching the latent complex through αvβ8-RGD association and recruiting membrane-bound matrix metalloproteinases (e.g., MMP-14) in proximity for further proteolytic cleavage ①. Active TGF-β can act on resident fibroblasts, inducing its trans-differentiation into myofibroblasts, which are the major contributor to excessive ECM (e.g., collagen) deposition and fibrosis. The myofibroblasts can further activate TGF-β in a contractile force-dependent manner through the αvβ6-RGD association ②. The active TGF-β can in turn act on epithelial cells, fibroblasts, and myofibroblasts in a paracrine/autocine manner, and thus form a feed-forward loop for a sustained TGF-β activation and fibrogenesis. Of note, sustained activation of TGF-β can also induce the epithelial–mesenchymal transition (EMT) of epithelial cells with the assistance of integrin α3β1, which forms a complex with TGF-β type I and II receptors (TβRI/II) and E-cadherin, facilitating β-catenin/Smad2 complex formation and nuclear translocation. LAP: latency-associated peptide, LTBP: latent TGF-β binding protein, SLC: small latent complex, LLC: large latent complex.CC BY · PubMed Central
Fig. 2 Activation of TGF-β recruits mesenchymal stem cells (MSCs) during bone remodeling. TGF-β1 is released from the bone matrix and activated during osteoclast-mediated bone resorption, creating a gradient. TGF-β1 induces migration of MSCs to the bone remodeling sites to couple bone resorption and formation. The bone-resorptive microenvironment also provides signals (e.g., IGF-1) that direct the lineage-specific differentiation of MSCs. In addition, PTH orchestrates signaling of local factors and thus regulates cellular activities, including those of MSCs, T cells, and other PTH-responsive cells in the bone marrow to coordinate bone remodeling
Fig. 2 Activation of TGF-β recruits mesenchymal stem cells (MSCs) during bone remodeling. TGF-β1 is released from the bone matrix and activated during osteoclast-mediated bone resorption, creating a gradient. TGF-β1 induces migration of MSCs to the bone remodeling sites to couple bone resorption and formation. The bone-resorptive microenvironment also provides signals (e.g., IGF-1) that direct the lineage-specific differentiation of MSCs. In addition, PTH orchestrates signaling of local factors and thus regulates cellular activities, including those of MSCs, T cells, and other PTH-responsive cells in the bone marrow to coordinate bone remodelingCC BY · PubMed Central
Fig. 3 Common genetic disorders with aberrant TGF-β activity. ① Mutations in genes involved in the synthesis/assembly of extracellular matrix (ECM), e.g., Fibrillin-1 (FBN1), cause compromised matrix sequestration of the large latent complex of TGF-β and excessive TGF signaling, ultimately resulting in genetic disorders such as Marfan syndrome (MFS) and stiff skin syndrome (SSKS). ② Mutations in the region encoding latency-associated peptide (LAP) increase the release of active TGF-β, and cause Camurati–Engelmann disease (CED). ③ Mutations in genes encoding TGF-β type I and II receptors (TβRI/II) lead to compensatory synthesis of TGF-β ligand, and cause Loeys–Dietz syndrome (LDS). ④ Mutations in smads repressor, such as SKI, super-activate TGF-β signaling and causes Shprintzen–Goldberg syndrome (SGS) phenotypes. VSMC vascular smooth muscle cells
Fig. 3 Common genetic disorders with aberrant TGF-β activity. ① Mutations in genes involved in the synthesis/assembly of extracellular matrix (ECM), e.g., Fibrillin-1 (FBN1), cause compromised matrix sequestration of the large latent complex of TGF-β and excessive TGF signaling, ultimately resulting in genetic disorders such as Marfan syndrome (MFS) and stiff skin syndrome (SSKS). ② Mutations in the region encoding latency-associated peptide (LAP) increase the release of active TGF-β, and cause Camurati–Engelmann disease (CED). ③ Mutations in genes encoding TGF-β type I and II receptors (TβRI/II) lead to compensatory synthesis of TGF-β ligand, and cause Loeys–Dietz syndrome (LDS). ④ Mutations in smads repressor, such as SKI, super-activate TGF-β signaling and causes Shprintzen–Goldberg syndrome (SGS) phenotypes. VSMC vascular smooth muscle cellsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 598 references

Research works printed but not linked: 3

  1. Derynck R., Miyazono K. The TGF-[beta] Family (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 2008.
  2. Derynck, R. & Feng, X. H. TGF-beta receptor signaling. Biochim. Biophys. Acta 1333, F105–150 (1997).
  3. Hasegawa, Y. et al. Transforming growth factor-beta1 level correlates with angiogenesis, tumor progression, and prognosis in patients with nonsmall cell lung carcinoma. Cancer 91, 964–971 (2001). · DOI · Paper page

Cited by

See all 414

Metadata

Authors
Xu, X., Zheng, L., Yuan, Q., Zhen, G., Crane, J. L., Zhou, X., & Cao, X.
Affiliations
  • Sichuan University (CN)
  • Johns Hopkins University (US)
Corresponding author
  • Zhou, Xuedong
  • Cao, Xu
Venue
Bone Research
Published
2018-01-31
Volume
6
Issue
1
Pages
2-2
ISSN
  • 2095-4700 (ISSN-L)
  • 2095-6231
OpenAlex
W2797460017
Cited by
414
References
598
Citations by year
2026: 43 · 2025: 46 · 2024: 56 · 2023: 58 · 2022: 81 · 2021: 57 · 2020: 34 · 2019: 27 · 2018: 11
FWCI
11.47
Type
journal article
Language
en
Open access
Licence
Locations
  • Bone Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • York University
  • National Natural Science Foundation of China (81771099, 2016JY0006)
  • Department of Science and Technology of Sichuan Province (81771099, 2016JY0006, 2017TD0016)
  • Sichuan University
  • National Institutes of Health
  • West China Hospital, Sichuan University
  • National Institute of Diabetes and Digestive and Kidney Diseases (Z01DK057501, R01DK057501)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR063943, R01AR071432, K08AR064833)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
TGF-beta, TGF-beta signaling, stem cells, tissue homeostasis, latent TGF-beta complex, extracellular matrix, ligand activation, tissue regeneration, fibrosis, metastasis, osteoarthritis, immune disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transforming growth factor‐β in stem cells and tissue homeostasis. https://app.cochat.ai/papers/10.1038/s41413-017-0005-4
The paper
Xu, X., Zheng, L., Yuan, Q., Zhen, G., Crane, J. L., Zhou, X., & Cao, X. (2018). Transforming growth factor‐β in stem cells and tissue homeostasis. Bone Research. https://doi.org/10.1038/s41413-017-0005-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.